Pharmstandard (Pharmaceuticals) Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Employees
-
1,068
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
5
- Investments
-
31
Pharmstandard (Pharmaceuticals) General Information
Description
Manufacturer of pharmaceutical products based in Dolgoprudny, Russia. The company's products help in the treatment of cardiovascular diseases, diabetes mellitus, growth hormone deficiency, gastroenterological and infectious diseases, neurological and metabolic disorders, oncology and a variety of other diseases.
Contact Information
Website
www.pharmstd.com(Operating Subsidiary)
Corporate Office
- 5B, Likhachyovsky Proezd
- Dolgoprudny, 141701
- Russia
Corporate Office
- 5B, Likhachyovsky Proezd
- Dolgoprudny, 141701
- Russia
Pharmstandard (Pharmaceuticals) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Pharmstandard (Pharmaceuticals) Comparisons
Industry
Financing
Details
Pharmstandard (Pharmaceuticals) Competitors (9)
One of Pharmstandard (Pharmaceuticals)’s 9 competitors is Angelini Pharma España, a Corporation company based in Barcelona, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Angelini Pharma España | Corporation | Barcelona, Spain | ||||
| Angelini Pharma Portugal | Corporation | Oeiras, Portugal | ||||
| J. B. Chemicals & Pharmaceuticals | Private Equity-Backed | Mumbai, India | ||||
| Casper Pharma | Corporate Backed or Acquired | East Brunswick, NJ | ||||
| Angelini Pharma Türkiye | Corporation | Istanbul, Turkey |
Pharmstandard (Pharmaceuticals) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Pharmstandard (Pharmaceuticals) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Pharmstandard (Pharmaceuticals) Investments & Acquisitions (31)
Pharmstandard (Pharmaceuticals)’s most recent deal was a Merger/Acquisition with Nanolek. The deal was made on 02-Sep-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Nanolek | 02-Sep-2022 | Merger/Acquisition | Biotechnology | ||
| PET-Technology | 18-Jul-2018 | Merger/Acquisition | Clinics/Outpatient Services | ||
| OncoTartis | 11-Dec-2017 | Later Stage VC | Drug Discovery | ||
| TearSolutions | 06-Dec-2017 | Early Stage VC | Drug Discovery | ||
| Viriom | 06-Dec-2017 | Later Stage VC | Drug Discovery |
Pharmstandard (Pharmaceuticals) Exits (13)
Pharmstandard (Pharmaceuticals)’s most recent exit was on 05-Dec-2017 from Neon Therapeutics. The exit was categorized as with 11 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Neon Therapeutics | 05-Dec-2017 | Completed |
|
||
| enGene (Biotechnology) | 01-Mar-2017 | Completed |
|
||
| Protagonist Therapeutics | 11-Aug-2016 | Completed |
|
||
| Argos Therapeutics | 28-Jul-2016 | Completed |
|
||
| Allena Pharmaceuticals | 09-Dec-2015 | Later Stage VC | Completed |
|
Pharmstandard (Pharmaceuticals) Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Nanolek | Moscow, Russia | 2011 | |
| PET-Technology | Balashikha, Russia | 2011 |
Pharmstandard (Pharmaceuticals) FAQs
-
When was Pharmstandard (Pharmaceuticals) founded?
Pharmstandard (Pharmaceuticals) was founded in 2003.
-
Where is Pharmstandard (Pharmaceuticals) headquartered?
Pharmstandard (Pharmaceuticals) is headquartered in Dolgoprudny, Russia.
-
What is the size of Pharmstandard (Pharmaceuticals)?
Pharmstandard (Pharmaceuticals) has 1,068 total employees.
-
What industry is Pharmstandard (Pharmaceuticals) in?
Pharmstandard (Pharmaceuticals)’s primary industry is Pharmaceuticals.
-
Is Pharmstandard (Pharmaceuticals) a private or public company?
Pharmstandard (Pharmaceuticals) is a Private company.
-
What is Pharmstandard (Pharmaceuticals)’s current revenue?
The current revenue for Pharmstandard (Pharmaceuticals) is .
-
How much funding has Pharmstandard (Pharmaceuticals) raised over time?
Pharmstandard (Pharmaceuticals) has raised $880M.
-
Who are Pharmstandard (Pharmaceuticals)’s investors?
Bristley Enterprises and Pharmstandard Leksredstva have invested in Pharmstandard (Pharmaceuticals).
-
Who are Pharmstandard (Pharmaceuticals)’s competitors?
Angelini Pharma España, Angelini Pharma Portugal, J. B. Chemicals & Pharmaceuticals, Casper Pharma, and Angelini Pharma Türkiye are some of the 9 competitors of Pharmstandard (Pharmaceuticals).
-
When was Pharmstandard (Pharmaceuticals) acquired?
Pharmstandard (Pharmaceuticals) was acquired on 14-Sep-2016.
-
Who acquired Pharmstandard (Pharmaceuticals)?
Pharmstandard (Pharmaceuticals) was acquired by Augment Investments.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
